Cerebral Aneurysm: Clinical Trials

4 trials for Cerebral Aneurysm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 withdrawn, 1 active not recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Withdrawn 3, Active not recruiting 1
Phase 11Withdrawn 1

Follow Cerebral Aneurysm: new trials by email Literature Review of Cerebral Aneurysm trials Research Report on Cerebral Aneurysm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
Microsurgical clipping, Endovascular treatment, Sirolimus - Cerebral Aneurysm
Phase 2Active not recruitingUniversity of Miami262021-10-272026-10-27
Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage
Tissue Plasminogen Activator - Subarachnoid Hemorrhage, Cerebral Vasospasm
Phase 1 / Phase 2WithdrawnRush University Medical Center2015-03-012015-11-11
Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)
clevidipine - Subarachnoid Hemorrhage, Cerebral Aneurysm
Phase 2WithdrawnHenry Ford Health System2014-03-012023-02-01
Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial
Estradiol, Placebo - Cerebral Aneurysm, Menopause
Phase 2WithdrawnRush University Medical Center2013-04-012021-01-05

Narrower conditions

Intracranial Aneurysm (4)  ·  Subarachnoid Hemorrhage (2)  ·  Vasospasm, Intracranial (2)  ·  Aneurysm (1)  ·  Hydrocephalus (1)

Broader conditions

Brain Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Cerebrovascular Disorders (4)  ·  Intracranial Arterial Diseases (4)  ·  Nervous System Diseases (4)  ·  Vascular Diseases (4)  ·  Aneurysm (3)  ·  Hemorrhage (2)  ·  Intracranial Hemorrhages (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Estradiol (1)  ·  Sirolimus (1)  ·  Tissue Plasminogen Activator (1)  ·  clevidipine (1)

Sponsors

Rush University Medical Center (2)  ·  Henry Ford Health System (1)  ·  University of Miami (1)

Countries

United States (4)

Top investigators

Barbara Soltes, MD (1)  ·  Michael Chen, MD (1)  ·  Mohammed Rehman, DO (1)  ·  Panayiots Varelas, MD, PhD (1)  ·  Robert M Starke, M.D. (1)  ·  Roham Moftakhar, MD (1)  ·  Stephan Munich, MD (1)  ·  Tamer Abdelhak, MD (1)

Results publications

PMID 21990811, PMID 22700728

NIH funding

R01NS111119 (1)